AZD2932 is primarily utilized in the field of medical research, particularly in oncology. It serves as a potent inhibitor targeting specific kinases involved in cancer cell proliferation and survival. Researchers employ this compound to study its effects on tumor growth and to evaluate its potential as a therapeutic agent in various cancer types. Its application extends to preclinical studies, where it helps in understanding the molecular pathways and mechanisms that drive cancer progression. Additionally, AZD2932 is used in the development of combination therapies, aiming to enhance the efficacy of existing treatments and overcome drug resistance in cancer patients.